Here's what Jim Cramer had to say about some of the stocks during the Mad Money Lightning Round:
Crispr Therapeutics (CRSP) - Get Report : "It's under pressure in the short term and has promise for the long term. But If you really like that business, you should be in Illumina (ILMN) - Get Report ."
Cramer and the AAP team are looking at opportunities for growth in their portfolio. Find out what they're telling their investment club members and get in on the conversation with a free trial subscription to Action Alerts Plus.
Over on Real Money, Cramer says he's not buying into all this recession talk. Get more of his insights with a free trial subscription to Real Money.
Search Jim Cramer's "Mad Money" trading recommendations using our exclusive "Mad Money" Stock Screener.
To read a full recap of this episode of "Mad Money," click here.
To watch replays of Cramer's video segments, visit the Mad Money page on CNBC.
To sign up for Jim Cramer's free Booyah! newsletter with all of his latest articles and videos please click here.
At the time of publication, Cramer's Action Alerts PLUS had a position PANW, AMZN.